Seastar Medical Holding Corp revenue

Seastar Medical Holding Corp's revenue was $1.2m in fiscal 2025, up 814.1% on the year before. Over the last twelve months it was $1.7m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Seastar Medical Holding Corp: revenue history, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	0	135	1,234	1,713
Growth on the year before	—	—	+814.1%	—
Gross profit	0	135	1,181	1,587
Gross margin	—	100.0%	95.7%	92.6%

US$ thousands unless shown otherwise. Fiscal quarters.

Seastar Medical Holding Corp: revenue history, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	68	67	293	338	183	420	495	615
Growth on the same quarter a year before	—	—	—	—	+169.1%	+526.9%	+68.9%	+82.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Seastar Medical Holding Corp	$1.7m	123.6%	—
Insight Molecular Diagnostics Inc.	$1.7m	-60.8%	14.9%
Femasys Inc	$2.3m	21.9%	24.3%
Volitionrx LTD	$2.5m	86.3%	68.0%
Pulse Biosciences, Inc.	$1.2m	100.0%	—
Icecure Medical Ltd.	$3.4m	2.7%	—

Compare with peers

Head to head: ICU vs IMDX FEMY vs ICU ICU vs VNRX ICU vs PLSE

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Seastar Medical Holding Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Seastar Medical Holding Corp.